Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced that its HiFi whole-genome sequencing technology has been adopted as a first-line approach in a major ...
MENLO PARK, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the Vega™ system, the company’s first ...
PacBio PACB recently announced the worldwide commercial availability of its SPRQ-Nx sequencing chemistry and new multi-use SMRT Cells for the Revio HiFi sequencing platform. The launch is expected to ...
PACB launched a joint FFPE workflow with Covaris to improve the sequencing of archived tumor samples. The solution enhances DNA recovery, boosting structural variant detection and mutation phasing ...
With the launch of Vega, PacBio offers a suite of long-range sequencing systems tailored to different customer needs. A first ...
Ark Invest CEO Cathie Wood is doubling down on genomics. What Happened: Pacific Biosciences of California Inc. (NASDAQ:PACB), known as PacBio, is biotech’s new kid on the block. The company's Vega ...
The National Institute on Aging’s Long Life Family Study (LLFS) selected PacBio technology to generate genomic and epigenomic data from as many as 7,800 participants. The effort will rely on PacBio’s ...
View Pacific Biosciences of California, Inc. PACB stock quote prices, financial information, real-time forecasts, and company news from CNN.
HiFi sequencing is adopted as a first-line approach in a major SUDC study sequencing 200 family trios. PACB shares rose 10.8% after reporting preliminary 2025 revenue of $160M, with Q4 revenue of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results